Former Senior Vice President of Clinical Development at Syneos HealthDr Fuller brings over 30 years’…
31
May
Related Posts
Race appoints Dr David Fuller Chief Medical Officer
Race Develops Improved IV Formulation of ZantreneRace-Develops-Improved-IV-Formulation-of-ZantreneDownload To discuss or comment on this announcement please visit our Investor Hub.
Race secures fifth US patent for ZantreneRace Oncology (“Race”) is pleased to announce that it has been issued a new patent…
